NCT05075369

Brief Summary

Disc hemorrhages are a known risk factor for progression of glaucoma. A positive water drinking test is also associated with progression of primary open glaucoma. The purpose of this study is to determine if patients with normal tension glaucoma and disc hemorrhages have a positive water drinking test. Patients with normal tension glaucoma and a disc hemorrhage will be recruited to undergo a water drinking test prior to any change in their treatment.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 19, 2021

Completed
12 days until next milestone

Study Start

First participant enrolled

October 1, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 12, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2022

Completed
Last Updated

October 12, 2021

Status Verified

September 1, 2021

Enrollment Period

6 months

First QC Date

September 19, 2021

Last Update Submit

September 29, 2021

Conditions

Keywords

normal tension glaucomadisc hemorrhageswater drinking test

Outcome Measures

Primary Outcomes (1)

  • Change in baseline intraocular pressure(IOP) with water drinking test

    The change in intraocular pressure in patients with normal tension glaucoma and a disc hemorrhage after undergoing the water drinking test will be measured with Goldmann applanation tonometry. A change from baseline IOP of 5 mm Hg is considered abnormal .

    The water drinking test takes 60 minutes, and the participant is then finished and can leave.

Study Arms (2)

baseline Intraocular pressure

NO INTERVENTION

The participants will have their intraocular pressure measured with Goldmann Application Tonometry immediately prior to beginning the water drinking test.

Change in Intraocular pressure with Water drinking test

ACTIVE COMPARATOR

The participants will undergo the water drinking test as previously described, i.e. after drinking 800 mls of water over a 5 minute period, the intraocular pressure will be measured immediately after completion of ingestion, followed by intraocular pressure measurements every 15 minutes for 60 minutes, using etc Goldmann apllantion tonometer.

Diagnostic Test: water drinking test

Interventions

water drinking testDIAGNOSTIC_TEST

Water drinking test-glaucoma diagnostic test - marker for outflow facility reserve to detect IOP instability when the body ingests 800 ml of water within a 5 minute period of time

Change in Intraocular pressure with Water drinking test

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of normal tension glaucoma by a fellowship trained glaucoma specialist,
  • Clinical diagnosis of a disc hemorrhage diagnosed by a fellowship trained glaucoma specialist,
  • Must be able to swallow water
  • Must be able to be positioned to allow accurate measurement of the Intraocular pressure with a slit lamp mounted Goldmann applanation tonometer
  • Must have a smooth corneal surface to allow for accurate Goldmann application tonometry measurement
  • Outpatient
  • A sufficient level of education to understand study procedures and be able to communicate with site personnel

You may not qualify if:

  • History of refractive surgery,
  • Active ocular infection,
  • Pregnancy,
  • Cardiac or renal diseases, history of urinary retention,
  • Corneal abnormalities preventing reliable IOP measurements,
  • Previous trabeculectomy or glaucoma shunt surgery,
  • Previous laser iridotomy,
  • Cognitive impairment or language barrier preventing ability to provide an informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Susanna R Jr, Vessani RM, Sakata L, Zacarias LC, Hatanaka M. The relation between intraocular pressure peak in the water drinking test and visual field progression in glaucoma. Br J Ophthalmol. 2005 Oct;89(10):1298-301. doi: 10.1136/bjo.2005.070649.

    PMID: 16170120BACKGROUND
  • Susanna R Jr, Clement C, Goldberg I, Hatanaka M. Applications of the water drinking test in glaucoma management. Clin Exp Ophthalmol. 2017 Aug;45(6):625-631. doi: 10.1111/ceo.12925. Epub 2017 Mar 9.

    PMID: 28164419BACKGROUND
  • Ishida K, Yamamoto T, Sugiyama K, Kitazawa Y. Disk hemorrhage is a significantly negative prognostic factor in normal-tension glaucoma. Am J Ophthalmol. 2000 Jun;129(6):707-14. doi: 10.1016/s0002-9394(00)00441-4.

    PMID: 10926977BACKGROUND

MeSH Terms

Conditions

Low Tension Glaucoma

Condition Hierarchy (Ancestors)

GlaucomaOcular HypertensionEye DiseasesOptic Nerve Diseases

Study Officials

  • Lisa Gould, MD FRCS

    University of Manitoba

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lisa Gould, MD, FRCS

CONTACT

Karla Zuniga, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: patients with a diagnosis of normal tension glaucoma and noted to have a disc hemorrhage
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lisa Gould Associate Professor

Study Record Dates

First Submitted

September 19, 2021

First Posted

October 12, 2021

Study Start

October 1, 2021

Primary Completion

April 1, 2022

Study Completion

April 1, 2022

Last Updated

October 12, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in the paper or poster , after deidentification (text, tables, figures, and appendices) will be available

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Immediately upon publication and for 36 months afterwards
Access Criteria
Researchers who provide a methodologically sound proposal.